8PI0

NMR2 Structure of KRAS G12V (GMPPNP bound) in complex with 5-(1H-indol-2-l)piperazin-2-one

PDB DOI: https://doi.org/10.2210/pdb8PI0/pdb
BMRB: 34827

Classification: ONCOPROTEIN
Organism(s): Homo sapiens
Expression System: Escherichia coli BL21(DE3)
Mutation(s): Yes

Deposited: 2023-06-20 Released: 2024-07-10
Deposition Author(s): Buetikofer, M., Orts, J.
Funding Organization(s): Swiss Cancer League

Experimental Data Snapshot

Method: SOLUTION NMR
Conformers Calculated: 4
Conformers Submitted: 4
Selection Criteria: structures with the lowest energy

wwPDB Validation 3D Report Full Report

This is version 1.0 of the entry. See complete history.

Literature

NMR2 Structure of KRAS G12V (GMPPNP bound) in complex with 5-(1H-indol-2-l)piperazin-2-one

Buetikofer, M., Orts, J.

To be published.

Macromolecule Content

Total Structure Weight: 19.38 kDa
Atom Count: 1,360
Modelled Residue Count: 168
Deposited Residue Count: 168
Unique protein chains: 1

Macromolecules

Find similar proteins by:

(by identity cutoff) | 3D Structure

Entity ID: 1
Molecule	Chains	Sequence Length	Organism	Details	Image
V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog, isoform CRA_b	A	168	Homo sapiens	Mutation(s): 1 Gene Names: KRAS, hCG_14731
Entity Groups
Sequence Clusters	30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
Sequence Annotations Expand
Reference Sequence

Small Molecules

Ligands 1 Unique
ID	Chains	Name / Formula / InChI Key	2D Diagram	3D Interactions
YVW (Subject of Investigation/LOI) Query on YVW Download Ideal Coordinates CCD File SDF format, chain B [auth A] MOL2 format, chain B [auth A]	B [auth A]	(5~{S})-5-(1~{H}-indol-2-yl)piperazin-2-one C₁₂ H₁₃ N₃ O AKZZWJXICXKZDI-NSHDSACASA-N		Interactions Focus chain B [auth A]

Experimental Data & Validation

Experimental Data

Method: SOLUTION NMR
Conformers Calculated: 4
Conformers Submitted: 4
Selection Criteria: structures with the lowest energy

Structure Validation

View Full Validation Report

Entry History & Funding Information

Deposition Data

Released Date: 2024-07-10

Deposition Author(s):

Funding Organization	Location	Grant Number
Swiss Cancer League	Switzerland	KFS-4903-08-2019

Revision History (Full details and data files)

Version 1.0: 2024-07-10
Type: Initial release

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.